NCT00621998View on ClinicalTrials.gov

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

June 30, 2004

Conditions
Neuroleptic-Induced Tardive Dyskinesia
Interventions
DRUG

risperidone

0.5-6 mg/day

DRUG

olanzapine

2.5-20 mg/day

Trial Locations (1)

33058

Taoyuan Mental Hospital, Taoyuan District

All Listed Sponsors
collaborator

Department of Health

AMBIG

lead

Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

OTHER_GOV

NCT00621998 - Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia | Biotech Hunter | Biotech Hunter